MED-EL Cochlear Implant Becomes First FDA-Approved Option for Children Seven Months and Older

FDA approves expanded indication for MED-EL cochlear implants for children seven months and older with bilateral sensorineural hearing loss.
Medical Device Network on MSN

MED-EL’s cochlear implants secure expanded approval in infants

The US Food and Drug Administration (FDA) has approved an expanded indication for MED-EL’s SYNCHRONY cochlea implants in ...
Medical Dialogues

Infants born with hearing loss show disruptions in brain design, underscoring the urgency of intervention: Study

Infants born deaf or hard of hearing show adverse changes in how their brains organize and specialize, but exposure to sound and language may help them develop more normally, according to ...
FOX59 News

UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss

Sheffield, UK, July 1 2025 – Rinri Therapeutics, a world leading company focused on transforming sensorineural hearing loss (SNHL) with regenerative cell therapy, is pleased to announce the approval ...
The Caledonian-Record

Sound Pharmaceuticals Receives FDA Breakthrough Therapy Designation for SPI-1005 to Treat Meniere’s Disease

SPI-1005 is the first drug to achieve its co-primary endpoints, involving clinically relevant improvements in PTA and WIN, in a pivotal Phase 3 randomized, double blinded, placebo-controlled trial ...